{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:01:01Z","timestamp":1793638861484,"version":"4.5.1"},"reference-count":119,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2020,12,31]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Neurological disorders (ND) are the central nervous system (CNS) related complications\noriginated by enhanced oxidative stress, mitochondrial failure and overexpression of proteins\nlike S100B. S100B is a helix-loop-helix protein with the calcium-binding domain associated with\nvarious neurological disorders through activation of the MAPK pathway, increased NF-kB expression\nresulting in cell survival, proliferation and gene up-regulation. S100B protein plays a crucial\nrole in Alzheimer\u2019s disease, Parkinson\u2019s disease, multiple sclerosis, Schizophrenia and epilepsy because\nthe high expression of this protein directly targets astrocytes and promotes neuroinflammation.\nUnder stressful conditions, S100B produces toxic effects mediated through receptor for advanced\nglycation end products (AGE) binding. S100B also mediates neuroprotection, minimizes\nmicrogliosis and reduces the expression of tumor necrosis factor (TNF-alpha) but that are concentration-\ndependent mechanisms. Increased level of S100B is useful for assessing the release of inflammatory\nmarkers, nitric oxide and excitotoxicity dependent neuronal loss. The present review\nsummarizes the role of S100B in various neurological disorders and potential therapeutic measures\nto reduce the prevalence of neurological disorders.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x18666200729100427","type":"journal-article","created":{"date-parts":[[2020,8,9]],"date-time":"2020-08-09T08:06:16Z","timestamp":1596960376000},"page":"265-277","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders"],"prefix":"10.2174","volume":"19","author":[{"given":"Urvashi","family":"Langeh","sequence":"first","affiliation":[{"name":"Department of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsher","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Neuropharmacology, ISF College of Pharmacy, Moga, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/ijms17020189","volume":"17","author":"Kovacs G.G.","year":"2016","unstructured":"Kovacs G.G.; Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine. Int J Mol Sci 2016,17(2),189","journal-title":"Int J Mol Sci"},{"key":"ref=2","first-page":"376","volume":"7","author":"Chen X.","year":"2012","unstructured":"Chen X.; Guo C.; Kong J.; Oxidative stress in neurodegenerative diseases. Neural Regen Res 2012,7(5),376-385","journal-title":"Neural Regen Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"Zorov D.B.","year":"2014","unstructured":"Zorov D.B.; Juhaszova M.; Sollott S.J.; Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014,94(3),909-950","journal-title":"Physiol Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3164734","DOI":"10.1155\/2016\/3164734","volume":"2016","author":"Nita M.","year":"2016","unstructured":"Nita M.; Grzybowski A.; The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid Med Cell Longev 2016,2016,3164734","journal-title":"Oxid Med Cell Longev"},{"key":"ref=5","first-page":"2003","volume":"8","author":"Guo C.","year":"2013","unstructured":"Guo C.; Sun L.; Chen X.; Zhang D.; Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 2013,8(21),2003-2014","journal-title":"Neural Regen Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/217037","author":"Sharma P.","year":"2012","unstructured":"Sharma P.; Jha A.B.; Dubey R.S.; Pessarakli M.; Reactive oxygen species, oxidative damage, and antioxidative defense mechanism in plants under stressful conditions. J Bot 2012,1-26","journal-title":"J Bot"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1046\/j.1471-4159.1997.68062227.x","volume":"68","author":"Bola\u00f1os J.P.","year":"1997","unstructured":"Bola\u00f1os J.P.; Almeida A.; Stewart V.; Peuchen S.; Land J.M.; Clark J.B.; Heales S.J.; Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem 1997,68(6),2227-2240","journal-title":"J Neurochem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1034\/j.1600-079X.2001.300201.x","volume":"30","author":"Acu\u00f1a-Castroviejo D.","year":"2001","unstructured":"Acu\u00f1a-Castroviejo D.; Mart\u00edn M.; Mac\u00edas M.; Escames G.; Le\u00f3n J.; Khaldy H.; Reiter R.J.; Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001,30(2),65-74","journal-title":"J Pineal Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1089\/ars.2008.2234","volume":"11","author":"Knott A.B.","year":"2009","unstructured":"Knott A.B.; Bossy-Wetzel E.; Nitric oxide in health and disease of the nervous system. Antioxidants Redox Signaling 2009,11(3),541-553","journal-title":"Antioxidants Redox Signaling"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1152\/japplphysiol.00524.2016","volume":"121","author":"Pannala V.R.","year":"2016","unstructured":"Pannala V.R.; Camara A.K.; Dash R.K.; Modeling the detailed kinetics of mitochondrial cytochrome c oxidase: Catalytic mechanism and nitric oxide inhibition. J Appl Physiol 2016,121(5),1196-1207","journal-title":"J Appl Physiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/1471-2407-10-476","volume":"10","author":"Cancemi P.","year":"2010","unstructured":"Cancemi P.; Di Cara G.; Albanese N.N.; Costantini F.; Marabeti M.R.; Musso R.; Lupo C.; Roz E.; Pucci-Minafra I.; Large-scale proteomic identification of S100 proteins in breast cancer tissues. BMC Cancer 2010,10(1),476","journal-title":"BMC Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.bbrc.2004.07.096","volume":"322","author":"Marenholz I.","year":"2004","unstructured":"Marenholz I.; Heizmann C.W.; Fritz G.; S100 proteins in mouse and man: from evolution to function and pathology including an update of the nomenclature. Biochem Biophys Res Commun 2004,322(4),1111-1122","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=13","first-page":"276","volume":"61","author":"Yardan T.","year":"2011","unstructured":"Yardan T.; Erenler A.K.; Baydin A.; Aydin K.; Cokluk C.; Usefulness of S100B protein in neurological disorders. J Pak Med Assoc 2011,61(3),276-281","journal-title":"J Pak Med Assoc"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/biom8020042","volume":"8","author":"Grzybowska E.A.","year":"2018","unstructured":"Grzybowska E.A.; Calcium-binding proteins with disordered structure and their role in secretion, storage, and cellular signaling. Biomolecules 2018,8(2),42","journal-title":"Biomolecules"},{"key":"ref=15","first-page":"207","volume":"1498","author":"Roland K.","year":"2000","unstructured":"Roland K.; Lyons G.E.; Sch\u00e4fer B.W.; Heizmann C.W.; Transcriptional regulation of S100A1 and expression during mouse heart development. Biochimica et Biophysica Acta (BBA)-. Molecular Cell Research 2000,1498(2-3),207-219","journal-title":"Molecular Cell Research"},{"key":"ref=16","first-page":"391136","author":"Chin Y.","year":"2018","unstructured":"Chin Y.; Khan M.I.; Yuan T.; Chou R.H.; S100A4 inhibits cell proliferation by interfering with the RAGE V domain-S100A1. bioRxiv 2018,391136","journal-title":"bioRxiv"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.neurobiolaging.2008.05.017","volume":"31","author":"Bianchi R.","year":"2010","unstructured":"Bianchi R.; Giambanco I.; Donato R.; S100B\/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1\u03b2 and TNF-\u03b1. Neurobiol Aging 2010,31(4),665-677","journal-title":"Neurobiol Aging"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0197-4580(01)00233-0","volume":"22","author":"Lam A.G.","year":"2001","unstructured":"Lam A.G.; Koppal T.; Akama K.T.; Guo L.; Craft J.M.; Samy B.; Schavocky J.P.; Watterson D.M.; Van Eldik L.J.; Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol Aging 2001,22(5),765-772","journal-title":"Neurobiol Aging"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1021\/bi00384a033","volume":"26","author":"Baudier J.","year":"1987","unstructured":"Baudier J.; Mochly-Rosen D.; Newton A.; Lee S.H.; Koshland D.E.; Cole R.D.; Comparison of S100b protein with calmodulin: interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C. Biochemistry 1987,26(10),2886-2893","journal-title":"Biochemistry"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"Hol E.M.","year":"2015","unstructured":"Hol E.M.; Pekny M.; Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol 2015,32,121-130","journal-title":"Curr Opin Cell Biol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jnc.14011","volume":"143","author":"Brandt R.","year":"2017","unstructured":"Brandt R.; Bakota L.; Microtubule dynamics and the neurodegenerative triad of Alzheimer\u2019s disease: The hidden connection. J Neurochem 2017,143(4),409-417","journal-title":"J Neurochem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11596-017-1732-x","volume":"37","author":"Ma R.H.","year":"2017","unstructured":"Ma R.H.; Zhang Y.; Hong X.Y.; Zhang J.F.; Wang J.Z.; Liu G.P.; Role of microtubule-associated protein tau phosphorylation in Alzheimer\u2019s disease. J Huazhong Univ Sci Technolog Med Sci 2017,37(3),307-312","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"539581","DOI":"10.1155\/2010\/539581","volume":"2010","author":"Leclerc E.","year":"2010","unstructured":"Leclerc E.; Sturchler E.; Vetter S.W.; The S100B\/RAGE axis in Alzheimer\u2019s disease. Cardiovasc Psychiatry Neurol 2010,2010,539581","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1046\/j.1471-4159.1997.69062294.x","volume":"69","author":"Hu J.","year":"1997","unstructured":"Hu J.; Ferreira A.; Van E.L.J.; S100\u03b2 induces neuronal cell death through nitric oxide release from astrocytes. J Neurochem 1997,69(6),2294-2301","journal-title":"J Neurochem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0969-9961(02)00017-7","volume":"12","author":"Arimoto T.","year":"2003","unstructured":"Arimoto T.; Bing G.; Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration. Neurobiol Dis 2003,12(1),35-45","journal-title":"Neurobiol Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/bs.apha.2017.09.003","volume":"82","author":"Dawson T.M.","year":"2018","unstructured":"Dawson T.M.; Dawson V.L.; Nitric oxide signaling in neurodegeneration and cell death. Adv Pharmacol 2018,82,57-83","journal-title":"Adv Pharmacol"},{"key":"ref=27","first-page":"993","volume":"1793","author":"Estelle L.","year":"2009","unstructured":"Estelle L.; Fritz G.; Vetter S.W.; Heizmann C.W.; Binding of S100 proteins to RAGE: an update. Biochimica et Biophysica Acta (BBA). Mol Cell Res 2009,1793(6),993-1007","journal-title":"Mol Cell Res"},{"key":"ref=28","first-page":"35","volume":"40","year":"2013","unstructured":"Potential roles of S100B in schizophrenia. Arch ClinPsychiatry (S\u00e3o Paulo) Johann, S.H.; Bernstein, B. Bogerts; Gon\u00e7alves, C2013,40(1),35-40","journal-title":"Arch ClinPsychiatry (S\u00e3o Paulo)"},{"key":"ref=29","first-page":"158","volume":"71","year":"2015","unstructured":"Age-related changes in S100\u03b2protein immunoreactivity in the periaqueductal gray (PAG) in rats. Med Weter Rycerz, K.; Krawczyk, A.; Jaworska-Adamu, J. Krawczyk-Mar\u0107; I.; Szalak, R2015,71(3),158-162","journal-title":"Med Weter"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12311-011-0262-5","volume":"10","author":"Vig P.J.","year":"2011","unstructured":"Vig P.J.; Hearst S.; Shao Q.; Lopez M.E.; Murphy H.A.; Safaya E.; Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Cerebellum 2011,10(2),254-266","journal-title":"Cerebellum"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41380-018-0036-2","volume":"24","author":"Toda T.","year":"2019","unstructured":"Toda T.; Parylak S.L.; Linker S.B.; Gage F.H.; The role of adult hippocampal neurogenesis in brain health and disease. Mol Psychiatry 2019,24(1),67-87","journal-title":"Mol Psychiatry"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.02.001","volume":"136","author":"Dossi E.","year":"2018","unstructured":"Dossi E.; Vasile F.; Rouach N.; Human astrocytes in the diseased brain. Brain Res Bull 2018,136,139-156","journal-title":"Brain Res Bull"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s11064-009-9915-x","volume":"34","author":"Nogueira M.I.","year":"2009","unstructured":"Nogueira M.I.; Abbas S.Y.; Campos L.G.M.; Allemandi W.; Lawson P.; Takada S.H.; Azmitia E.C.; S100\u03b2 protein expression: gender- and age-related daily changes. Neurochem Res 2009,34(8),1355-1362","journal-title":"Neurochem Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1523\/JNEUROSCI.1731-05.2005","volume":"25","author":"van Praag H.","year":"2005","unstructured":"van Praag H.; Shubert T.; Zhao C.; Gage F.H.; Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci 2005,25(38),8680-8685","journal-title":"J Neurosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/ijms20092146","volume":"20","author":"Fairless R.","year":"2019","unstructured":"Fairless R.; Williams S.K.; Diem R.; Calcium-binding proteins as determinants of central nervous system neuronal vulnerability to disease. Int J Mol Sci 2019,20(9),2146","journal-title":"Int J Mol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1152\/physrev.00005.2006","volume":"87","author":"Satr\u00fastegui J.","year":"2007","unstructured":"Satr\u00fastegui J.; Pardo B.; Del Arco A.; Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev 2007,87(1),29-67","journal-title":"Physiol Rev"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/147342202320883551","volume":"1","author":"Schwaller B.","year":"2002","unstructured":"Schwaller B.; Meyer M.; Schiffmann S.; \u2018New\u2019 functions for \u2018old\u2019 proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice. Cerebellum 2002,1(4),241-258","journal-title":"Cerebellum"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0891-0618(97)10013-8","volume":"14","author":"DeFelipe J.","year":"1997","unstructured":"DeFelipe J.; Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 1997,14(1),1-19","journal-title":"J Chem Neuroanat"},{"key":"ref=39","first-page":"201","volume":"55","author":"Druga R.","year":"2009","unstructured":"Druga R.; Neocortical inhibitory system. Folia Biol (Praha) 2009,55(6),201-217","journal-title":"Folia Biol (Praha)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1152\/physrev.00007.2017","volume":"97","author":"Pelkey K.A.","year":"2017","unstructured":"Pelkey K.A.; Chittajallu R.; Craig M.T.; Tricoire L.; Wester J.C.; McBain C.J.; Hippocampal GABAergic inhibitory interneurons. Physiol Rev 2017,97(4),1619-1747","journal-title":"Physiol Rev"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.celrep.2017.10.006","volume":"21","author":"Li J.T.","year":"2017","unstructured":"Li J.T.; Xie X.M.; Yu J.Y.; Sun Y.X.; Liao X.M.; Wang X.X.; Su Y.A.; Liu Y.J.; Schmidt M.V.; Wang X.D.; Si T.M.; Suppressed calbindin levels in hippocampal excitatory neurons mediate stress-induced memory loss. Cell Rep 2017,21(4),891-900","journal-title":"Cell Rep"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.33549\/physiolres.931930","volume":"59","author":"Barinka F.","year":"2010","unstructured":"Barinka F.; Druga R.; Calretinin expression in the mammalian neocortex: a review. Physiol Res 2010,59(5),665-677","journal-title":"Physiol Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1749-6632.1994.tb44424.x","volume":"747","author":"Disterhoft J.F.","year":"1994","unstructured":"Disterhoft J.F.; Moyer J.R.; Thompson L.T.; The calcium rationale in aging and Alzheimer\u2019s disease. Evidence from an animal model of normal aging. Ann N Y Acad Sci 1994,747,382-406","journal-title":"Ann N Y Acad Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pneurobio.2017.03.008","volume":"153","author":"Tyebji S.","year":"2017","unstructured":"Tyebji S.; Hannan A.J.; Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington\u2019s disease. Prog Neurobiol 2017,153,18-45","journal-title":"Prog Neurobiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.wneu.2017.09.074","volume":"108","author":"Abboud T.","year":"2017","unstructured":"Abboud T.; Mende K.C.; Jung R.; Czorlich P.; Vettorazzi E.; Priefler M.; Kluge S.; Westphal M.; Regelsberger J.; Prognostic value of early S100 calcium binding protein B and neuron-specific enolase in patients with poor-grade aneurysmal subarachnoid hemorrhage: a pilot study. World Neurosurg 2017,108,669-675","journal-title":"World Neurosurg"},{"key":"ref=46","first-page":"1356","year":"2002","unstructured":"G\u00fcnter Fritz; and B. W. Schafer. S100 proteins: structure, functions and pathology. Front Biosci H. Claus W2002,1356-1368","journal-title":"Front Biosci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/pro.5560040416","volume":"4","author":"Donaldson C.","year":"1995","unstructured":"Donaldson C.; Barber K.R.; Kay C.M.; Shaw G.S.; Human S100b protein: formation of a tetramer from synthetic calcium-binding site peptides. Protein Sci 1995,4(4),765-772","journal-title":"Protein Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1021\/bi972635p","volume":"37","year":"1998","unstructured":"Baldisseri, M.; Rustandi, R. R.; Weber, D. J. Solution structure of calcium-bound rat S100B (\u03b2\u03b2) as determined by nuclear magnetic resonance spectroscopy. Biochemistry D. Alexander C. Donna1998,37(9),2729-2740","journal-title":"Biochemistry"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e109287","DOI":"10.1371\/journal.pone.0109287","volume":"9","author":"Denessiouk K.","year":"2014","unstructured":"Denessiouk K.; Permyakov S.; Denesyuk A.; Permyakov E.; Johnson M.S.; Two structural motifs within canonical EF-hand calcium-binding domains identify five different classes of calcium buffers and sensors. PLoS One 2014,9(10),e109287","journal-title":"PLoS One"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/BJ20070255","volume":"405","author":"Gifford J.L.","year":"2007","unstructured":"Gifford J.L.; Walsh M.P.; Vogel H.J.; Structures and metal-ion-binding properties of the Ca binding helix-loop-helix EF-hand motifs. Biochem J 2007,405(2),199-221","journal-title":"Biochem J"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1432-1033.1978.tb12539.x","volume":"89","author":"Isobe T.","year":"1978","unstructured":"Isobe T.; Okuyama T.; The amino-acid sequence of S-100 protein (PAP I-b protein) and its relation to the calcium-binding proteins. Eur J Biochem 1978,89(2),379-388","journal-title":"Eur J Biochem"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.1016\/S0021-9258(19)83895-4","volume":"261","author":"Baudier J.","year":"1986","unstructured":"Baudier J.; Glasser N.; Gerard D.; Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn regulates Ca binding on S100b protein. J Biol Chem 1986,261(18),8192-8203","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0361-9230(95)00040-2","volume":"37","author":"Zimmer D.B.","year":"1995","unstructured":"Zimmer D.B.; Cornwall E.H.; Landar A.; Song W.; The S100 protein family: history, function, and expression. Brain Research Bulletin 1995,37,417-429","journal-title":"Brain Research Bulletin"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","volume":"8","author":"Xia C.","year":"2018","unstructured":"Xia C.; Braunstein Z.; Toomey A.C.; Zhong J.; Rao X.; S100 proteins as an important regulator of macrophage inflammation. Front Immunol 2018,8,1908-1919","journal-title":"Front Immunol"},{"key":"ref=55","first-page":"1232","volume":"3","author":"Estelle L.","year":"2011","unstructured":"Estelle L.; Heizmann C.W.; The importance of Ca \/ Zn signaling S100 proteins and RAGE in translational medicine. Front Biosci 2011,3(2),1232-1262","journal-title":"Front Biosci"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.str.2010.05.017","volume":"18","author":"Koch M.","year":"2010","unstructured":"Koch M.; Chitayat S.; Dattilo B.M.; Schiefner A.; Diez J.; Chazin W.J.; Fritz G.; Structural basis for ligand recognition and activation of RAGE. Structure 2010,18(10),1342-1352","journal-title":"Structure"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"40762","DOI":"10.1074\/jbc.M110.169276","volume":"285","author":"Park H.","year":"2010","unstructured":"Park H.; Adsit F.G.; Boyington J.C.; The 1.5 \u00c5 crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem HaJeung2010,285(52),40762-40770","journal-title":"J Biol Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0301-0082(02)00079-5","volume":"68","author":"Auld D.S.","year":"2002","unstructured":"Auld D.S.; Kornecook T.J.; Bastianetto S.; Quirion R.; Alzheimer\u2019s disease and the basal forebrain cholinergic system: relations to \u03b2-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002,68(3),209-245","journal-title":"Prog Neurobiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"Serrano-Pozo A.","year":"2011","unstructured":"Serrano-Pozo A.; Frosch M.P.; Masliah E.; Hyman B.T.; Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011,1(1),a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-2094-7-6","volume":"7","author":"M\u00e1rcia C.","year":"2010","unstructured":"M\u00e1rcia C.; Camozzato A.L.; Ferreira E.D.; Piazenski I.; Kochhann R.; Guilherme O.D.; Mazzini, S.; Diogo O.S. and Luis V.P. Serum levels of S100B and NSE proteins in Alzheimer\u2019s disease patients. J Neuroinflammation 2010,7(1),6","journal-title":"J Neuroinflammation"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0165-0173(00)00051-5","volume":"35","author":"Law A.","year":"2001","unstructured":"Law A.; Gauthier S.; Quirion R.; Say NO to Alzheimer\u2019s disease: the putative links between nitric oxide and dementia of the Alzheimer\u2019s type. Brain Res Brain Res Rev 2001,35(1),73-96","journal-title":"Brain Res Brain Res Rev"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"9163040","DOI":"10.1155\/2018\/9163040","volume":"2018","author":"Weng M.","year":"2018","unstructured":"Weng M.; Xie X.; Liu C.; Lim K.L.; Zhang C.W.; Li L.; The sources of reactive oxygen species and its possible role in the pathogenesis of Parkinson\u2019s disease. Parkinsons Dis 2018,2018,9163040","journal-title":"Parkinsons Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0197-4580(98)00003-7","volume":"19","author":"Arendt T.","year":"1998","unstructured":"Arendt T.; Holzer M.; Fruth R.; Br\u00fcckner M.K.; G\u00e4rtner U.; Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol Aging 1998,19(1),3-13","journal-title":"Neurobiol Aging"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1126\/sciadv.aaq1702","volume":"4","author":"Joana C.","year":"2018","unstructured":"Joana C.; Morris V.K.; Cardoso I.; Leal S.S.; Mart\u00ednez J.; Botelho H.M.; G\u00f6bl. C. The neuronal S100B protein is a calcium-tuned suppressor of amyloid-\u03b2 aggregation. Sci Adv 2018,4(6),1702","journal-title":"Sci Adv"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1471-4159.2004.02864.x","volume":"92","author":"Ahmed N.","year":"2005","unstructured":"Ahmed N.; Ahmed U.; Thornalley P.J.; Hager K.; Fleischer G.; M\u00fcnch G.; Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer\u2019s disease and link to cognitive impairment. J Neurochem 2005,92(2),255-263","journal-title":"J Neurochem"},{"key":"ref=66","first-page":"1615","volume":"13","author":"Tobon-Velasco C.","year":"2014","unstructured":"Tobon-Velasco C.; Elvis Cuevas J.; Torres-Ramos M. A.; Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress CNS \u00a0 Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS \u00a0 Neurological Disorders) 2014,13(9),1615-1626","journal-title":"CNS \u00a0 Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS \u00a0 Neurological Disorders)"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semcancer.2017.10.005","volume":"49","author":"Ahmad S.","year":"2018","unstructured":"Ahmad S.; Khan M.Y.; Rafi Z.; Khan H.; Siddiqui Z.; Rehman S.; Shahab U.; Khan M.S.; Saeed M.; Alouffi S.; Khan M.S.; Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer. Semin Cancer Biol 2018,49,29-36","journal-title":"Semin Cancer Biol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4236\/ojpsych.2012.22014","volume":"2","author":"M\u00f8rkeberg N.F.","year":"2012","unstructured":"M\u00f8rkeberg N.F.; Parkinson\u2019s disease and affective disorder: The temporal relationship. Open J Psychiatr 2012,2(02),96","journal-title":"Open J Psychiatr"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/mds.21033","volume":"21","author":"Gatev P.","year":"2006","unstructured":"Gatev P.; Darbin O.; Wichmann T.; Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord 2006,21(10),1566-1577","journal-title":"Mov Disord"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"Trist B.G.","year":"2019","unstructured":"Trist B.G.; Hare D.J.; Double K.L.; Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 2019,18(6),e13031","journal-title":"Aging Cell"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"Pacher P.","year":"2007","unstructured":"Pacher P.; Beckman J.S.; Liaudet L.; Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007,87(1),315-424","journal-title":"Physiol Rev"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/ars.2007.1858","volume":"10","author":"Nakamura T.","year":"2008","unstructured":"Nakamura T.; Lipton S. A.; Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases Antioxidants \u00a0 redox signaling 2008,10(1),87-102","journal-title":"Antioxidants \u00a0 redox signaling"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1089\/152308603322110896","volume":"5","author":"Ebadi M.","year":"2003","unstructured":"Ebadi M.; Sharma S.K.; Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson\u2019s disease. Antioxid Redox Signal 2003,5(3),319-335","journal-title":"Antioxid Redox Signal"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","volume":"135","author":"Sathe K.","year":"2012","unstructured":"Sathe K.; Maetzler W.; Lang J.D.; Mounsey R.B.; Fleckenstein C.; Martin H.L.; Schulte C.; Mustafa S.; Synofzik M.; Vukovic Z.; Itohara S.; Berg D.; Teismann P.; S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-\u03b1 pathway. Brain 2012,135(Pt 11),3336-3347","journal-title":"Brain"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/656481","volume":"2010","author":"Sorci G.","year":"2010","unstructured":"Sorci G.; Bianchi R.; Riuzzi F.; Tubaro C.; Arcuri C.; Giambanco I.; Donato R.; S100B protein, a damage-associated molecular pattern protein in the brain and heart, and beyond. Cardiovasc Psychiatry Neurol 2010,2010,1-13","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.2174\/0929867323666160812151356","volume":"23","author":"Jim\u00e9nez-Jim\u00e9nez F.J.","year":"2016","unstructured":"Jim\u00e9nez-Jim\u00e9nez F.J.; Alonso-Navarro H.; Herrero M.T.; Garc\u00eda-Mart\u00edn E.; Ag\u00fandez J.A.G.; An update on the role of nitric oxide in the neurodegenerative processes of Parkinson\u2019s disease. Curr Med Chem 2016,23(24),2666-2679","journal-title":"Curr Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"480707","DOI":"10.1155\/2010\/480707","volume":"2010","author":"Steiner J.","year":"2010","unstructured":"Steiner J.; Myint A.M.; Schiltz K.; Westphal S.; Bernstein H.G.; Walter M.; Schroeter M.L.; Schwarz M.J.; Bogerts B.; S100B serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovasc Psychiatry Neurol 2010,2010,480707","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","volume":"9","author":"Ingrid L.","year":"2011","unstructured":"Ingrid L.; Heyman R.; Multiple sclerosis: pathogenesis and treatment Current neuropharmacology 2011,9(3),409-416 https:\/\/dx.doi.org\/10.2174%2F157015911796557911","journal-title":"Current neuropharmacology"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","volume":"17","author":"Lassmann H.","year":"2007","unstructured":"Lassmann H.; Br\u00fcck W.; Lucchinetti C.F.; The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007,17(2),210-218","journal-title":"Brain Pathol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1007\/s12035-015-9336-6","volume":"53","author":"Barateiro A.","year":"2016","unstructured":"Barateiro A.; Afonso V.; Santos G.; Cerqueira J.J.; Brites D.; van Horssen J.; Fernandes A.; S100B as a potential biomarker and therapeutic target in multiple sclerosis. Mol Neurobiol 2016,53(6),3976-3991","journal-title":"Mol Neurobiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1474-4422(02)00102-3","volume":"1","author":"Smith K.J.","year":"2002","unstructured":"Smith K.J.; Lassmann H.; The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002,1(4),232-241","journal-title":"Lancet Neurol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/brain\/awf165","volume":"125","author":"Petzold A.","year":"2002","unstructured":"Petzold A.; Eikelenboom M.J.; Gveric D.; Keir G.; Chapman M.; Lazeron R.H.C.; Cuzner M.L.; Polman C.H.; Uitdehaag B.M.; Thompson E.J.; Giovannoni G.; Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain 2002,125(Pt 7),1462-1473","journal-title":"Brain"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1352458507082061","volume":"14","author":"Rejdak K.","year":"2008","unstructured":"Rejdak K.; Petzold A.; Stelmasiak Z.; Giovannoni G.; Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis. Mult Scler 2008,14(1),59-66","journal-title":"Mult Scler"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-0404.2010.01393.x","volume":"123","author":"Bartosik-Psujek H.","year":"2011","unstructured":"Bartosik-Psujek H.; Psujek M.; Jaworski J.; Stelmasiak Z.; Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone. Acta Neurol Scand 2011,123(4),252-256","journal-title":"Acta Neurol Scand"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3109\/08916934.2014.930734","volume":"47","author":"O\u2019Connell K.E.","year":"2014","unstructured":"O\u2019Connell K.E.; Mok T.; Sweeney B.; Ryan A.M.; Dev K.K.; The use of cytokine signature patterns: separating drug na\u00efve, interferon and natalizumab-treated multiple sclerosis patients. Autoimmunity 2014,47(8),505-511","journal-title":"Autoimmunity"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fimmu.2020.00374","volume":"11","author":"Guerrero B.L.","year":"2020","unstructured":"Guerrero B.L.; Sicotte N.L.; Microglia in multiple sclerosis: friend or foe? Front Immunol 2020,11,374","journal-title":"Front Immunol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fneur.2015.00180","volume":"6","author":"Correale J.","year":"2015","unstructured":"Correale J.; Farez M.F.; The role of astrocytes in multiple sclerosis progression. Front Neurol 2015,6,180","journal-title":"Front Neurol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","volume":"258","author":"Axelsson M.","year":"2011","unstructured":"Axelsson M.; Malmestr\u00f6m C.; Nilsson S.; Haghighi S.; Rosengren L.; Lycke J.; Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol 2011,258(5),882-888","journal-title":"J Neurol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"134347","DOI":"10.1016\/j.neulet.2019.134347","volume":"710","author":"Kumar Sahel D.","year":"2019","unstructured":"Kumar Sahel D.; Kaira M.; Raj K.; Sharma S.; Singh S.; Mitochondrial dysfunctioning and neuroinflammation: Recent highlights on the possible mechanisms involved in Traumatic Brain Injury. Neurosci Lett 2019,710,134347-134353","journal-title":"Neurosci Lett"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"Uttara B.","year":"2009","unstructured":"Uttara B.; Singh A.V.; Zamboni P.; Mahajan R.T.; Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009,7(1),65-74","journal-title":"Curr Neuropharmacol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/j.bbadis.2016.12.020","volume":"1863","author":"Kozlov A.V.","year":"2017","unstructured":"Kozlov A.V.; Bahrami S.; Redl H.; Szabo C.; Alterations in nitric oxide homeostasis during traumatic brain injury. Biochim Biophys Acta Mol Basis Dis 2017,1863(10 Pt B),2627-2632","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00701-016-3046-3","volume":"159","author":"Thelin E.P.","year":"2017","unstructured":"Thelin E.P.; Nelson D.W.; Bellander B.M.; A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir (Wien) 2017,159(2),209-225","journal-title":"Acta Neurochir (Wien)"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1097\/CCM.0b013e3181809750","volume":"36","author":"Sanchez-Pe\u00f1a P.","year":"2008","unstructured":"Sanchez-Pe\u00f1a P.; Pereira A.R.; Sourour N.A.; Biondi A.; Lejean L.; Colonne C.; Boch A.L.; Al Hawari M.; Abdennour L.; Puybasset L.; S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med 2008,36(8),2267-2273","journal-title":"Crit Care Med"},{"key":"ref=94","first-page":"1008-1022","author":"Donato R.","year":"1793","unstructured":"Donato R.; Sorci G.; Riuzzi F.; Arcuri C.; Bianchi R.; Brozzi F.; I.S100B\u2019s double life: intracellular regulator and extracellular signal. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1793(6),1008-1022","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"key":"ref=95","first-page":"1008","volume":"1793","author":"Acta B.","year":"2009","unstructured":"Acta B.; (BBA)-Molecular. Cell Res 2009,1793(6),1008-1022","journal-title":"Cell Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0197-0186(01)00047-X","volume":"39","author":"Koppal T.","year":"2001","unstructured":"Koppal T.; Lam A.G.; Guo L.; Van E.L.J.; S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia. Neurochem Int 2001,39(5-6),401-407","journal-title":"Neurochem Int"},{"key":"ref=97","first-page":"7","volume":"XII","author":"Anthony M.","year":"2003","unstructured":"Anthony M.;  Brain Edema 2003,XII,7-10","journal-title":"Brain Edema"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1089\/neu.2008.0738","volume":"26","author":"Blyth B.J.","year":"2009","unstructured":"Blyth B.J.; Farhavar A.; Gee C.; Hawthorn B.; He H.; Nayak A.; St\u00f6cklein V.; Bazarian J.J.; Brian B.J.; Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J Neurotrauma 2009,26(9),1497-1507","journal-title":"J Neurotrauma"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0361-9230(03)00091-1","volume":"61","author":"Petzold A.","year":"2003","unstructured":"Petzold A.; Keir G.; Lim D.; Smith M.; Thompson E.J.; Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. Brain Res Bull 2003,61(3),281-285","journal-title":"Brain Res Bull"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"27584","DOI":"10.1038\/srep27584","volume":"6","author":"Hong W.","year":"2016","unstructured":"Hong W.; Zhao M.; Li H.; Peng F.; Wang F.; Li N.; Xiang H.; Su Y.; Huang Y.; Zhang S.; Zhao G.; Zhou R.; Mao L.; Lin Z.; Fang Y.; Zhang Q.; Xie B.;  Sci Rep Higher plasma S100B concentrations in schizophrenia patients, and dependently associated with inflammatory markers2016,6,27584","journal-title":"Sci Rep"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-244X-13-146","volume":"13","author":"O\u2019Connell K.","year":"2013","unstructured":"O\u2019Connell K.; Thakore J.; Dev K.K.; Levels of S100B are raised in female patients with schizophrenia. BMC Psychiatry 2013,13(1),146","journal-title":"BMC Psychiatry"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","volume":"35","author":"Bitanihirwe B.K.","year":"2011","unstructured":"Bitanihirwe B.K.; Woo T.U.W.; Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 2011,35(3),878-893","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fphys.2015.00139","volume":"6","author":"Nasyrova R.F.","year":"2015","unstructured":"Nasyrova R.F.; Ivashchenko D.V.; Ivanov M.V.; Neznanov N.G.; Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. Front Physiol 2015,6,139","journal-title":"Front Physiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/pcn.12024","volume":"67","author":"Yelmo-Cruz S.","year":"2013","unstructured":"Yelmo-Cruz S.; Morera-Fumero A.L.; Abreu-Gonz\u00e1lez P.; S100B and schizophrenia. Psychiatry Clin Neurosci 2013,67(2),67-75","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"27584","DOI":"10.1038\/srep27584","volume":"6","author":"Hong W.","year":"2016","unstructured":"Hong W.; Zhao M.; Li H.; Peng F.; Wang F.; Li N.; Higher plasma S100B concentrations in schizophrenia patients, and dependently associated with inflammatory markers. Sci Rep 2016,6,27584 https:\/\/dx.doi.org\/10.1038%2Fsrep27584","journal-title":"Sci Rep"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","volume":"46","author":"Fisher R.S.","year":"2005","unstructured":"Fisher R.S.; van Emde Boas W.; Blume W.; Elger C.; Genton P.; Lee P.; Engel J.Jr.; Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005,46(4),470-472","journal-title":"Epilepsia"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12974-018-1109-5","volume":"15","author":"Vizuete A.F.K.","year":"2018","unstructured":"Vizuete A.F.K.; Hansen F.; Negri E.; Leite M.C.; de Oliveira D.L.; Gon\u00e7alves C.A.; Effects of dexamethasone on the Li-pilocarpine model of epilepsy: protection against hippocampal inflammation and astrogliosis. J Neuroinflammation 2018,15(1),68","journal-title":"J Neuroinflammation"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"9732854","DOI":"10.1155\/2017\/9732854","volume":"2017","author":"Tang N.Y.","year":"2017","unstructured":"Tang N.Y.; Lin Y.W.; Ho T.Y.; Cheng C.Y.; Chen C.H.; Hsieh C.L.; Long-term intake of Uncaria rhynchophylla reduces S100B and RAGE protein levels in kainic acid-induced epileptic seizures rats. Evid Based Complement Alternat Med 2017,2017,9732854","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","volume":"53","author":"Marchi N.","year":"2012","unstructured":"Marchi N.; Granata T.; Ghosh C.; Janigro D.; Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia 2012,53(11),1877-1886","journal-title":"Epilepsia"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2009.05.073","volume":"1282","author":"Somera-Molina K.C.","year":"2009","unstructured":"Somera-Molina K.C.; Nair S.; Van E.L.J.; Watterson D.M.; Wainwright M.S.; Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a \u2018two-hit\u2019 seizure model. Brain Res 2009,1282,162-172","journal-title":"Brain Res"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/brainsci8020033","volume":"8","author":"Haque A.","year":"2018","unstructured":"Haque A.; Polcyn R.; Matzelle D.; Banik N.L.; New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection. Brain Sci 2018,8(2),33","journal-title":"Brain Sci"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jnc.14574","volume":"148","author":"Michetti F.","year":"2019","unstructured":"Michetti F.; D\u2019Ambrosi N.; Toesca A.; Puglisi M. A.; Serrano A.; Marchese E.; Geloso M. C.; The S100B story: from biomarker to active factor in neural injury Neurochemistry 2019,148(2),168-187","journal-title":"Neurochemistry"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1034\/j.1600-0404.2003.00159.x","volume":"108","author":"Portela L.V.C.","year":"2003","unstructured":"Portela L.V.C.; Tort A.B.L.; Walz R.; Bianchin M.; Trevisol-Bittencourt P.C.; Wille P.R.; Cardoso R.C.; Ishida M.M.I.; vonWangenheim A.; Grisard E.C.; Steindel M.; Gon\u00e7alves C.A.; Souza D.O.; Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy. Acta Neurol Scand 2003,108(6),424-427","journal-title":"Acta Neurol Scand"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neulet.2010.08.036","volume":"484","author":"Lu C.","year":"2010","unstructured":"Lu C.; Li J.; Sun W.; Feng L.; Li L.; Liu A.; Li J.; Mao W.; Wei H.; Gao L.; Zhang X.; Huang Z.; Meng X.; Wang Y.; Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case-control study. Neurosci Lett 2010,484(2),139-142","journal-title":"Neurosci Lett"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/S0140-6736(99)01301-X","volume":"353","author":"Tergau F.","year":"1999","unstructured":"Tergau F.; Naumann U.; Paulus W.; Steinhoff B.J.; Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy. Lancet 1999,353(9171),2209","journal-title":"Lancet"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.seizure.2012.10.012","volume":"22","author":"Calik M.","year":"2013","unstructured":"Calik M.; Abuhandan M.; Sonmezler A.; Kandem\u0131r H.; Oz I.; Taskin A.; Selek S.; Iscan A.; Elevated serum S-100B levels in children with temporal lobe epilepsy. Seizure 2013,22(2),99-102","journal-title":"Seizure"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.seizure.2011.11.003","volume":"21","author":"Atici Y.","year":"2012","unstructured":"Atici Y.; Alehan F.; Sezer T.; Tuygun N.; Haberal A.; Yazici A.C.; Karacan C.D.; Serum S100B levels in children with simple febrile seizures. Seizure 2012,21(3),175-177","journal-title":"Seizure"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2013.10.040","volume":"558","author":"Calik M.","year":"2014","unstructured":"Calik M.; Abuhandan M.; Kandemir H.; G\u00fczel B.; Solmaz A.; Celik H.; Taskin A.; Iscan A.; Interictal serum S-100B protein levels in intractable epilepsy: a case-control study. Neurosci Lett 2014,558,58-61","journal-title":"Neurosci Lett"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1471-4159.1995.65010228.x","volume":"65","author":"Griffin W.S.T.","year":"1995","unstructured":"Griffin W.S.T.; Yeralan O.; Sheng J.G.; Boop F.A.; Mrak R.E.; Rovnaghi C.R.; Burnett B.A.; Feoktistova A.; Van Eldik L.J.; Overexpression of the neurotrophic cytokine S100 \u03b2 in human temporal lobe epilepsy. J Neurochem 1995,65(1),228-233","journal-title":"J Neurochem"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184275","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184275\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184275","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T14:14:40Z","timestamp":1640268880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184275\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x18666200729100427","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}